Preparing for the Bursting of the Psychedelic Hype Bubble.
David B. Yaden, James B. Potash, Roland R. Griffiths
JAMA Psychiatry October 1, 2022 DOI: 10.1001/jamapsychiatry.2022.2546 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Viewpoint Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | Psychedelic medicine Entheogenic treatment Hallucinogen-assisted therapy Mental health psychedelics Responsible psychedelic development Ethical psychedelic growth Sustainable psychedelic progress Regulated psychedelic innovation Psychedelic risk management Psychedelic scientific inquiry Ethical psychedelic frameworks Psychedelic regulatory guidelines Psychedelic training |
| Citations | 153 |
| Key points | Extreme shifts in public perception of psychedelics create impediments to clinical application, and claims not supported by evidence should be disputed. |
Abstract
This Viewpoint presents impediments to the clinical application of psychedelics created by extreme shifts in public perception while advocating further study and encouraging the dispute of claims not supported by available evidence.